ANIP

ANI Pharmaceuticals, Inc. Q1 Profit Increases, Beats Estimates

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced a profit for its first quarter that increased from last year and beat the Street estimates.

The company's earnings totaled $17.801 million, or $0.82 per share. This compares with $1.033 million, or $0.06 per share, in last year's first quarter.

Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $23.466 million or $1.21 per share for the period.

Analysts on average had expected the company to earn $1 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 28.7% to $137.430 million from $106.786 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance (GAAP) :

-Earnings (Q1): $17.801 Mln. vs. $1.033 Mln. last year. -EPS (Q1): $0.82 vs. $0.06 last year. -Revenue (Q1): $137.430 Mln vs. $106.786 Mln last year.

-Guidance: Full year EPS guidance: $4.26 to $4.67 Full year revenue guidance: $520 to $542 Mln

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.